| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/01/2000 | US6020462 Nucleic acids encoding the hypoxia inducible factor-1 |
| 02/01/2000 | US6020200 Encapsulation compositions and methods |
| 02/01/2000 | US6020197 Neuroblasts are dependant upon about 1 to 100 ng/ml of bfgf for long term maintenance. |
| 02/01/2000 | US6020196 Devices for harvesting and homogenizing adipose tissue containing autologous endothelial cells |
| 02/01/2000 | US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020192 Genes adapted for high level expression in mammalian cells, especially those of human origin. |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020182 Subunit respiratory syncytial virus vaccine preparation |
| 02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
| 02/01/2000 | US6020170 Method of preparing a monoclonal antibody |
| 02/01/2000 | US6020165 Cytikine signal regulators |
| 02/01/2000 | US6020164 Human RNA binding proteins |
| 02/01/2000 | US6020163 Lipocalin homolog |
| 02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
| 02/01/2000 | US6020159 3-dehydroquinate synthase |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6020152 Lymphocyte-associated cell surface protein |
| 02/01/2000 | US6020149 Combining a microbially required nucleotide phosphatase, a nucleoside phosphate and the substance to be tested, and assessing the extent of degradation of the nucleoside phosphate in the presence and absence of the substance |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6020007 Pyruvate, d-beta-hydroxybutyrate and acetoacetate anions are the only monoanionic organic metabolic anions present |
| 02/01/2000 | US6019993 Virus-inactivated 2-component fibrin glue |
| 02/01/2000 | US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 02/01/2000 | CA2139392C Continuously calibrating temperature controller |
| 02/01/2000 | CA2069085C Activatable fibrinolytic and anti-thrombotic proteins |
| 02/01/2000 | CA2009198C Monoclonal antibody for differentiating hiv-2 from hiv-1 seropositive individuals |
| 01/30/2000 | CA2244554A1 Inhibition of graft versus host disease |
| 01/27/2000 | WO2000004185A1 Adenoviral based promoter assay |
| 01/27/2000 | WO2000004183A1 Bone morphogenic protein |
| 01/27/2000 | WO2000004176A1 Process to collect metabolites from modified nectar by insects |
| 01/27/2000 | WO2000004173A1 Methods and means to modulate programmed cell death in eukaryotic cells |
| 01/27/2000 | WO2000004169A1 New caspase homologue |
| 01/27/2000 | WO2000004160A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | WO2000004159A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | WO2000004158A2 Compositions and methods for fumonisin detoxification |
| 01/27/2000 | WO2000004157A2 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | WO2000004152A2 Androgen receptor coactivators |
| 01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
| 01/27/2000 | WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | WO2000004148A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
| 01/27/2000 | WO2000004141A2 Use of nucleic acid molecules as antiviral agents |
| 01/27/2000 | WO2000004140A1 71 human secreted proteins |
| 01/27/2000 | WO2000004137A1 Human aspartic proteases |
| 01/27/2000 | WO2000004051A2 Growth differentiation factor promoter and uses therefor |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004045A1 Axor10, a g-protein coupled receptor |
| 01/27/2000 | WO2000004043A1 Protease susceptibility ii |
| 01/27/2000 | WO2000004041A2 Methods and molecules relating to cd39-like polypeptides |
| 01/27/2000 | WO2000003726A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | WO2000003687A2 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | WO1999063096A3 Acyl coa:cholesterol acyltransferase related nucleic acid sequences |
| 01/27/2000 | WO1999063051A3 Bioengineered flat sheet graft prostheses |
| 01/27/2000 | WO1999063050A3 Method for preparation and in vivo administration of antigen presenting cell composition |
| 01/27/2000 | WO1999061639A3 Retroviral delivery system |
| 01/27/2000 | WO1999061623A3 Genetic method for producing riboflavin |
| 01/27/2000 | WO1999061599A3 Recombinant narbonolide polyketide synthase |
| 01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
| 01/27/2000 | WO1999054465A9 Gene encoding syntaxin interacting protein |
| 01/27/2000 | WO1999053085A3 Selective regulation of adenovirus production |
| 01/27/2000 | WO1999052925A9 Programmed cell death and caspase-12 |
| 01/27/2000 | DE19833476A1 New genetically modified, adherently growing CD34-negative stem cells for transfer of gene therapy constructs for treatment of immunodeficiency and metabolic disorders |
| 01/27/2000 | CA2337835A1 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | CA2337362A1 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | CA2337231A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | CA2335274A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
| 01/27/2000 | CA2335101A1 Androgen receptor coactivators |
| 01/27/2000 | CA2335099A1 New caspase homologue |
| 01/27/2000 | CA2335096A1 Methods and materials relating to novel cd39-like polypeptides |
| 01/27/2000 | CA2334161A1 Use of nucleic acid molecules as antiviral agents |
| 01/27/2000 | CA2334075A1 Bone morphogenic protein |
| 01/27/2000 | CA2334045A1 Adenoviral based promoter assay |
| 01/27/2000 | CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2333917A1 71 human secreted proteins |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/27/2000 | CA2333897A1 Process to collect metabolites from modified nectar by insects |
| 01/27/2000 | CA2333471A1 Human scad-related molecules, scrm-1 and scrm-2 |
| 01/27/2000 | CA2333467A1 Human presenilin-associated protein |
| 01/27/2000 | CA2332722A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | CA2327921A1 Compositions and methods for fumonisin detoxification |
| 01/27/2000 | CA2303062A1 Human aspartic proteases |
| 01/26/2000 | EP0974668A1 Use of adenoviral E4 reading frames to improve expression of a gene of interest |
| 01/26/2000 | EP0974661A1 Geranyl diphosphate synthase genes |
| 01/26/2000 | EP0974659A2 Viral nucleotide sequences |
| 01/26/2000 | EP0974657A1 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
| 01/26/2000 | EP0974651A1 Physiologically active protein originating in mammals |
| 01/26/2000 | EP0974648A1 Novel cell line and screening method with the use of the same |
| 01/26/2000 | EP0974111A1 Apparatus and method for automated protein design |
| 01/26/2000 | EP0974058A2 20 human secreted proteins |
| 01/26/2000 | EP0974057A1 Methods to detect hk2 polypeptides |
| 01/26/2000 | EP0974056A1 Prenatal diagnostic methods |
| 01/26/2000 | EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 01/26/2000 | EP0973928A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| 01/26/2000 | EP0973927A1 Chimeric adenoviral coat protein and methods of using same |
| 01/26/2000 | EP0973923A1 IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING |
| 01/26/2000 | EP0973920A1 An oleosin 5' regulatory region for the modification of plant seed lipid composition |
| 01/26/2000 | EP0973915A1 Recombinant microorganisms capable of fermenting cellobiose |
| 01/26/2000 | EP0973910A1 Bacillus thuringiensis toxins |
| 01/26/2000 | EP0973908A2 Plants with controlled side-shoot formation and/or controlled abscission area formation |
| 01/26/2000 | EP0973904A1 COMPOSITIONS AND USE OF M-CSF-alpha |